Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
1.270
+0.140 (12.39%)
At close: Aug 22, 2025, 4:00 PM
1.300
+0.030 (2.36%)
After-hours: Aug 22, 2025, 4:55 PM EDT

Rein Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
305015115142
Upgrade
Market Cap Growth
-48.14%234.56%38.39%-78.89%20.50%165.52%
Upgrade
Enterprise Value
24773-15-133
Upgrade
Last Close Price
1.272.303.052.3711.2620.80
Upgrade
PB Ratio
9.730.920.150.581.163.48
Upgrade
P/TBV Ratio
---0.581.163.48
Upgrade
Debt / Equity Ratio
--00.000.000.03
Upgrade
Quick Ratio
0.742.243.956.2810.193.49
Upgrade
Current Ratio
0.862.384.176.4610.694.12
Upgrade
Return on Equity (ROE)
-79.38%-82.37%-26.91%-87.41%-93.33%-150.00%
Upgrade
Return on Assets (ROA)
-18.24%-20.89%-14.99%-49.03%-51.30%-59.84%
Upgrade
Return on Capital (ROIC)
-20.42%-23.01%-16.40%-55.10%-58.74%-76.18%
Upgrade
Earnings Yield
-199.85%-126.19%-105.62%-253.93%-51.32%-50.00%
Upgrade
FCF Yield
-71.71%-44.73%-132.99%-231.03%-46.90%-48.41%
Upgrade
Buyback Yield / Dilution
-137.74%-290.09%-1.31%-2.23%-154.70%-42.11%
Upgrade
Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q